Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-07 4:32 pm Purchase |
2024-09-30 | 13G | Adagene Inc. ADAG |
Huang James | 4,015,000 7.300% |
1,265,000 (+46.00%) |
Filing History |
| 2024-10-29 4:05 pm Purchase |
2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,435,000 9.200% |
305,000 (+26.99%) |
Filing History |
| 2024-06-11 4:10 pm Sale |
2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,130,000 8.400% |
-1,565,000 (-58.07%) |
Filing History |
| 2024-02-13 4:30 pm Sale |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Huang James | 0 0.000% |
-176,667 (Position Closed) |
Filing History |
| 2024-01-26 08:31 am Purchase |
2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,695,000 19.990% |
268,000 (+11.04%) |
Filing History |
| 2024-01-19 08:37 am Purchase |
2024-01-18 | 13G | Adagene Inc. ADAG |
Huang James | 2,750,000 5.000% |
2,750,000 (New Position) |
Filing History |
| 2023-11-09 4:13 pm Purchase |
2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,427,000 18.000% |
677,000 (+38.69%) |
Filing History |
| 2023-10-04 5:26 pm Purchase |
2023-10-02 | 13G | Connect Biopharma Holdings Limited CNTB |
Huang James | 5,995,000 10.900% |
3,175,000 (+112.59%) |
Filing History |
| 2023-06-22 9:15 pm Purchase |
2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,750,000 13.000% |
520,000 (+42.28%) |
Filing History |
| 2023-05-17 07:30 am Purchase |
2023-05-17 | 13D | Windtree Therapeutics, Inc. WINT |
Huang James | 84 1.500% |
84 (New Position) |
Filing History |
| 2023-04-19 07:14 am Sale |
2023-04-18 | 13D | Windtree Therapeutics, Inc. WINT |
Huang James | 0 0.000% |
-84 (Position Closed) |
Filing History |
| 2023-04-10 11:22 am Purchase |
2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,230,000 9.200% |
1,230,000 (New Position) |
Filing History |
| 2023-03-10 12:15 pm Purchase |
2023-03-09 | 13G | Praxis Precision Medicines, Inc. PRAX |
Huang James | 176,667 5.100% |
176,667 (New Position) |
Filing History |
| 2023-02-23 4:31 pm Unchanged |
2023-02-22 | 13D | Windtree Therapeutics, Inc. WINT |
Huang James | 84 8.700% |
0 (Unchanged) |
Filing History |
| 2023-02-08 7:49 pm Purchase |
2023-01-30 | 13D | Windtree Therapeutics, Inc. WINT |
Huang James | 84 8.600% |
84 (New Position) |
Filing History |
| 2023-01-03 4:31 pm Purchase |
2022-12-22 | 13G | Connect Biopharma Holdings Limited CNTB |
Huang James | 2,820,000 5.100% |
2,820,000 (New Position) |
Filing History |